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Disorders involving dysfunctional sensory processing are characterized by an inability to
ﬁlter sensory information, particularly simultaneously arrivingmultimodal inputs.We exam-
ined the effects of prenatal exposure to valproic acid (VPA), a teratogen linked to sensory
dysfunction, on the behavior of juvenile and adult rats, and on the anatomy of the supe-
rior colliculus, a critical multisensory integration center in the brain. VPA-exposed rats
showed deﬁcits in colliculus-dependent behaviors including startle response, prepulse inhi-
bition, and nociceptive responses. Some deﬁcits reversed with age. Stereological analyses
revealed that colliculi of VPA-treated rats had signiﬁcantly fewer parvalbumin-positive neu-
rons, a subset of GABAergic cells.These results suggest that prenatalVPA treatment affects
the development of the superior colliculus and leads to persistent anatomical changes
evidenced by aberrant behavior in tasks that require sensory processing.
Keywords: sensory processing, valproic acid, superior colliculus, rat
INTRODUCTION
Several neurocognitive disorders in humans involve dysfunctional
sensory processing. These include but are not limited to autism
spectrum disorders, attention deﬁcit/hyperactivity disorders, fetal
valproate syndrome, and putative sensory processing disorders.
Sensory deﬁciencies in these disorders may manifest as hypo or
hypersensitivity to sensory stimuli.
While the etiology of most of these disorders is unknown, fetal
valproate syndrome is linked to embryologic insults with terato-
gens. Children exposed in utero to valproic acid (VPA)may present
with a host of developmental and behavioral delays and physical
malformations (Moore et al., 2000). Physical abnormalities range
from severe to subtle and include spina biﬁda, heart defects, joint
laxity, and facial dysmorphologies. Many exposed children lag in
motor function and coordination, speech and learning. They often
have decreased social interactions, hyperactivity, and difﬁculties
with attention. Furthermore, humans exposed prenatally to VPA
suffer from sensorimotor dysfunctions, most prominently hyper-
sensitivity to innocuous sensory stimuli (Ardinger et al., 1988).
Similar sensory dysfunction can be reproduced in experimen-
tal animals, including rats, by administering VPA to the pregnant
animal: offspring exhibit behavioral deﬁcits that closely resem-
ble those of humans with deﬁcient sensory processing, including
hypersensitivity to sensory stimuli (Rodier et al., 1997; Arndt
et al., 2005; Schneider and Przewlocki, 2005; Markram et al.,
2007;Markram andMarkram,2010). Thus, theVPA animalmodel
offers anopportunity to exploremechanismsof teratogen-induced
deﬁciencies in sensory processing.
Exposure to VPA likely affects a number of brain structures
involved in sensory functions. Indeed, anatomical and electro-
physiological abnormalities have been reported in a number of
brain regions of adult rats following exposure to VPA in utero.
These regions include the cerebral cortex, amygdala, cerebellum,
and brainstem (Markram et al., 2007; Rinaldi et al., 2007, 2008b;
Markram and Markram, 2010).
Another brain region presumably affected is the superior col-
liculus, which is critically involved in processing multisensory
information (Stein and Meredith, 1993). Functioning to process
and integrate visual, auditory, and somatosensory information and
regulate motor acts, this structure is likely involved in the expres-
sion of the abnormalities inherent in disorders that involve sensory
processing. For instance, animals exposed to VPA in utero dis-
play aberrant behaviors in auditory startle responses, sensorimotor
gating, and nociceptive processing (Vorhees, 1987; Schneider and
Przewlocki, 2005), behaviors that are mediated, at least in part, by
the superior colliculus (Redgrave et al., 1996; Fendt, 1999; Fendt
et al., 2001; Yeomans et al., 2006).
Here we test the hypothesis that prenatal VPA treatment alters
the superior colliculus, resulting in sensorimotor deﬁcits that per-
sist into adulthood.We report that prenatal VPA treatment results
in sensorimotor behavioral deﬁcits and anatomical abnormalities
in the superior colliculus.
MATERIALS AND METHODS
ANIMALS
Female Sprague Dawley rats (Harlan) were mated overnight and
vaginal lavage was used to test for the presence of sperm. The ﬁrst
day of gestation was designated as the day when the smear was
sperm-positive. In some cases timed-pregnant females were used.
Animals were exposed to a normal light/dark schedule. Females
raised their own litters. Offspringwere weaned on postnatal day 21
(PND21).Nomore than three siblings of the same sexwere housed
together in cages. Control rats and VPA-treated rats were housed
in separate cages. Animals had free access to food and water. All
experiments were carried out according to IACUC regulations and
federal guidelines.
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VPA ADMINISTRATION
Due to high rates of embryonic resorption and postnatal mor-
tality [even beyond weaning (PND 21+)], several methods of
VPA administration were employed. Table 1 summarizes various
modes used, the timing of administration, and their success in
terms of birth rate, litter size, adolescent survival rates, and sex
ratios.
For injections, sodium valproate (Sigma-Aldrich, St. Louis,
MO,USA) was dissolved in saline at a concentration of 250mg/ml
and the appropriate dose was administered intraperitoneally (ip).
Experiments reported here were carried out on animals that
received one of two VPA dosing schemes: (1) “single dose” (400–
600mg/kg) of VPA or saline delivered on E12.5 or (2) “multiple
doses” (200mg/kg) of VPA or saline delivered on E11–13.
The ﬁrst dosing scheme has been introduced by Rodier et al.
(1996) and used in several subsequent studies (Rodier et al., 1997;
Ingram et al., 2000; Schneider et al., 2001, 2006; Schneider and
Przewlocki, 2005; Stodgell et al., 2006;Wagner et al., 2006; Rinaldi
et al., 2008a,b). The second dosing scheme was included to resem-
ble more clinically relevant, multiple exposures to VPA. Dosing
schemes that consisted of more than 3 days of exposure, although
higher in clinical relevance, resulted in high rates of mortality (data
not shown) and were therefore not used.
Because offspring viability and sustainability of VPA-treated
dams was of particular difﬁculty, it is possible that the rats that did
survive prenatal exposure to VPA, and that were included in this
study, had relativelymild consequences, and that themore severely
affected died in utero or shortly after birth. The cohort of animals
that survived may therefore not represent the severity of VPA’s
effects on sensory processing. Moreover, the consequences of fetal
exposure to a teratogen are inﬂuenced by intrauterine position of
the pups (Lipton et al., 1998), further increasing the variability
within each litter.
BEHAVIOR
Behavioral experiments were carried out on offspring of VPA-
treated and control animals that received either (1) a single i.p.
injection of VPA (400 or 500mg/kg) or saline on E12.5 or (2)mul-
tiple day i.p. injections of VPA (200mg/kg) or saline on E11–13.
Unless indicated, all behaviors were assessed in juveniles (PND
22–28) and adults (PND >60). Behavioral testing was run at the
same time each day for each group of animals. Sample size for each
individual behavioral test can be found in Tables 2 and 3.
ACOUSTIC STARTLE RESPONSE AND PREPULSE INHIBITION
Acoustic startle response was measured using San Diego Instru-
ments SR-LAB® Startle Response System (San Diego, CA, USA).
Animals were tested in a ventilated enclosure mounted on a Plexi-
glas frame. Motion was detected and transduced by a piezoelectric
sensor below the Plexiglas frame. Subjects acclimated to the testing
chamber for 5min during which only background noise (68 dB)
was delivered. Acoustic stimuli of white noise between 69 and
113 dB were randomly presented for a duration of 40ms each.
Inter-trial intervals ranged between 5 and 10 s. Testing lasted
approximately 20min, during which the maximal velocity of the
animals’ startle response was measured. This metric, referred to as
startle amplitude, is measured in arbitrary units.
Prepulse inhibition (PPI) was measured using the same appa-
ratus. Both prepulse and pulse stimuli consisted of white noise
which were generated by the testing apparatus. Background level
was set at 68 dB, prepulse level at 80 dB and stimulus duration
was 20ms. Pulse level was 120 dB and duration was 40ms, the
interval between prepulse and pulse was 100ms and inter-trial
interval varied between 10 and 15 s. Percentage of PPI was calcu-
lated as: (amplitude of startle response)− (amplitude of prepulse
response)/(amplitude of startle response)× 100.
MECHANICAL NOCICEPTION
Von Frey rigid ﬁlaments were used to assess mechanical with-
drawal response probability. Rats were gently restrained by hand
during testing. Graded ﬁlaments of increasing force were applied
to the dorsal surface of the hindpaw or to the vibrissa pad until
bending to deliver calibrated force ranging from 0.2 to 180.0 g.
Response probability was calculated as number of times out of
ﬁve the subject withdrew or vocalized.
THERMAL NOCICEPTION
Thermal pain threshold was determined using the Hargreaves
method (Hargreaves et al., 1988). A radiant heat stimulus of 33˚C
Table 1 | Summary of success ofVPA administration paradigms.
VPA treatment Day(s) of
treatment
% Of females that
gave birth
Litter size
(average)
% Of pups that
reach PND 21
Total viable
offspring (average)
Offspring male:
female ratio
600mg/kg
VPA E12.5 57 9 50 4.5 1.5:1
Saline 88 10.3 69 7.1 1:1.5
500mg/kg
VPA E12.5 42 5.2 50 2.6 0.7/1
Saline 88 10.3 69 7.1 0.8/1
400mg/kg
VPA E12.5 100 7.7 74 5.7 1:2
Saline 88 10.3 69 7.1 0.8/1
200mg/kg
VPA E11–13 100 12.8 92 11.8 1.1/1
Saline 100 11 95 10.5 1.1/1
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Table 2 | Summary of behavioral results for groups receiving a single dose ofVPA or saline.
VPA on E12.5 n Control 12.5 n pValue
PPI%
Juvenile 3.9±5.6 29 20.7±4.9 18 0.03
Adult 21.4±11.6 8 19.4±27.9 3 1.00
von FREY FACE (g) 5/5
Juvenile 86.3±6.0 56 111±8.2 26 0.005
Adult 223±24 16 220±25 6 0.81
von FREY FOOT (g) 5/5
Juvenile 31±2.2 56 46±3.3 26 0.0002
Adult 140±19.7 16 167±13.3 6 0.21
THERMAL LATENCY (s)
Juvenile n/a n/a n/a n/a n/a
Adult 11.8±0.7 16 8.2±0.5 6 0.003
SOCIABILITY (s)
Juvenile 171±12 29 215±15 18 0.03
Adult 146±10 8 157±37 3 0.54
EXPLORATORY DISTANCE (ARBITRARY UNITS)
Juvenile 2225±62 27 1793±111 18 0.001
Adult 4691±259 8 4982±482 3 0.54
Data expressed as mean±SEM.
Table 3 | Summary of behavioral results for groups receiving multiple doses ofVPA or saline.
VPA on E11–13 n Control 11–13 n pValue
PPI%
Juvenile 18.1±3.6 34 28.9±5.4 21 0.12
Adult 60.3±4.4 13 24.3±14.2 11 0.11
von FREY FACE (g) 5/5
Juvenile 84.0±4.1 68 98±6.0 40 0.04
Adult 218±16.5 26 265±14.5 22 0.04
von FREY FOOT (g) 5/5
Juvenile 39±2.2 68 42±2.7 42 0.21
adult 165±13.7 26 142±11.3 22 0.11
THERMAL LATENCY (s)
Juvenile n/a n/a n/a n/a n/a
Adult 11.7±0.5 26 9.0±0.5 20 0.0003
SOCIABILITY (s)
Juvenile 189±15 33 225±13 21 0.12
Adult 165±12 13 138±27 10 0.66
EXPLORATORY DISTANCE (ARBITRARY UNITS)
Juvenile 1828±125 23 2203±111 21 0.06
Adult 4798±125 13 4483±162 11 0.11
Data expressed as mean±SEM.
(IITC, Woodland Hills, CA, USA) was applied to the plantar sur-
face of the rat’s hindpaw until it was withdrawn. A cutoff time of
20 s was used to prevent injury. The test was repeated three times
for each hindpaw. Data are reported as the average (of three trials)
latency to paw withdrawal. To prevent sensitization, at least 5min
separated each trial.
OPEN FIELD BEHAVIOR AND SOCIABILITY
A three-compartment chamber (dimensions: 90 cm× 50 cm×
32 cm) made of black plastic was used to assess open ﬁeld
and sociability (Crawley, 2004). For open ﬁeld behavior sub-
jects were placed in the middle chamber and a sliding door
revealed two chambers for the test rat to freely explore. Rats
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were video recorded for 5min and their behavior was analyzed
using Topscan (CleverSys, Reston, VA, USA) software. The dis-
tance (arbitrary units) traveled while exploring was used for data
analysis.
The same apparatus was used to assess sociability. Subjects
were placed in the middle (neutral) chamber and a sliding door
revealed two chambers (social and non-social) to the test rat. Each
of the two chambers held a clear perforated plexiglas sub-chamber
(dimensions: 20 cm× 20 cm× 20 cm) into which an age-matched
and sex-matched stranger rat was placed. The side with the sub-
chamber housing the stranger rat was designated as the “social”
chamber. Rats were video recorded for 5min and their behav-
ior was analyzed using Topscan software. Time spent in each
chamber was used for data analysis. The order of running the
open ﬁeld and sociability tests was counterbalanced for each
group.
ANATOMY
All anatomical experiments were carried out on adult (PND>60)
offspring of animals that received, on E12.5, a single 600mg/kg i.p.
injection of VPA or saline. See Figure 5 for sample size for each
stereological analysis.
IMMUNOHISTOCHEMISTRY
Rats were perfused transcardially with 4% paraformaldehyde,
brains were removed, placed in ﬁxative overnight and equili-
brated in a 30% sucrose solution. Fifty Micrometer thick coro-
nal sections were cut on a freezing stage microtome or cryostat
from Bregma −8.0 to −5.6mm (Paxinos and Watson, 1998).
Sections were washed with PBS and incubated in mouse anti-
parvalbumin (1:75,000; Swant, Bellinzona, Switzerland) or mouse
anti-NeuN (1:120,000, Sigma-Aldrich, St. Louis, MO, USA) and
0.4% Triton-X PBS for 48 h at room temperature. After washing,
sections were incubated for 1 h in biotinylated rabbit anti-mouse
(1:600; Jackson ImmunoResearch, West Grove, PA, USA) and
0.4% triton-X PBS. After PBS rinses, sections were incubated for
30min in ABC elite solution (Vector Laboratories, Burlingame,
CA, USA) and the reaction product developed using nickel-
DAB. Sections were air dried overnight, mounted, dehydrated,
and cover-slipped in DPX. Neutral red (1%) was used for Nissl
staining.
DOUBLE IMMUNOFLUORESCENCE
Rats were transcardially perfused with 4% paraformaldehyde,
brains removed and placed in ﬁxative overnight and placed in
cryoprotectant for 1week. After gelatin embedding, 50μm thick
coronal sections were cut on a cryostat from Bregma −8.0 to
−5.6mm, washed with PBS and incubated in blocking solution
(2% BSA in 0.1% Triton in 0.05M PBS) for 1 h. Sections were
then incubated for 48 h at room temperature in primary anti-
body, rabbit anti-GABA (1:100,000; Sigma-Aldrich), or mouse
anti-parvalbumin (1:60,000; Swant). After washing, sections were
incubated for 2 h at room temperature in secondary antibody
tagged with Cy3 or Cy2 (1:1000; Jackson ImmunoResearch). Slices
were dehydrated and mounted using DPX. Tissue was visualized
using an Olympus (Center Valley, PA, USA) Fluoview confocal
scanning system microscope.
STEREOLOGY
StereoInvestigator’s (MBF Biosciences, Williston, VT, USA) opti-
cal fractionator probe was used to obtain unbiased estimates of
cell number, cell density, and area volume. Counting frames were
50μm by 50μm; grid size was 305μm by 175μm; guard zones
were 5μm; and dissector height was 15μm. Whereas the borders
of the superﬁcial layer of the superior colliculus are distinct, the
borders of the intermediate and deep layers are not. To circumvent
any ambiguity, we deﬁned the lateral border of these regions as a
transverse line extending from the lateral edge of the superﬁcial
layer to the lateral most border of the periaqueductal gray (PAG;
see Figure 1).
Statistical analyses
For behavioral analyses, data collected from the single dose VPA
group was compared to the single dose saline group. Similarly,
data collected from themultiple doseVPA group was compared to
the multiple dose saline group. In most cases, comparisons were
made using the Mann–Whitney U non-parametric test for inde-
pendent samples. Startle responses, however, were tested using a
repeated-measures ANOVA with Bonferroni correction for mul-
tiple comparisons to determine signiﬁcance at individual decibel
levels.
For anatomical studies, we compared animals that received
a single dose of VPA (600mg/kg) at E12.5 to controls that
FIGURE 1 | Photomicrographs of Nissl-stained coronal sections through
the superior colliculus, depicting the regions used for stereological
analyses.We deﬁned the lateral border of the intermediate/deep layers of the
superior colliculus by a line extending from the lateral edge of the superﬁcial
layers to the lateral border of the periaqueductal gray (PAG). (A–C) Show
increasingly more posterior sections and subsequently adjusted borders.
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received saline at E12.5. All comparisons were made using the
Mann–Whitney U non-parametric test for independent samples.
RESULTS
BEHAVIOR
Previous studies have shown that the effects of prenatal exposure
to VPA on certain behavioral measures are correlated with the
postnatal age at which these behaviors are quantiﬁed (Markram
et al., 2007; Markram and Markram, 2010, #68472). We therefore
analyzed our experimental and control groups in a number of tests,
administered when they were juveniles (PND 21–30) and adults
(PND >60). We used two dosing paradigms: a single dose deliv-
ered at E12.5 and multiple doses delivered daily on E11–13 (see
Materials andMethods). Tables 2 and 3 summarize these ﬁndings.
STARTLE RESPONSE
A common ﬁnding in subjects with sensory processing distur-
bances is an abnormal response to auditory stimuli (Ayres, 1979),
which can bemeasured by the startle response. The acoustic startle
response quantiﬁes the velocity of movement in response to a sud-
den sound. The startle response of juvenile rats exposed in utero to
a single dose of VPA (n = 29) was signiﬁcantly different (ps< 0.05,
one-way ANOVA, Bonferroni post hoc) than that of age-matched
controls for several decibel levels (n = 18; Figure 2A). Rats treated
with a multiple injections of VPA responded similarly to con-
trols except for a signiﬁcantly lowered startle response at 97 dB
(Figure 2C). By contrast, in adults there were no signiﬁcant dif-
ferences in the startle responses for VPA-treated rats that received
either a single injection of VPA (n = 8) or multiple injections of
FIGURE 2 |VPA-treated rats exhibit abnormal startle responses and
prepulse inhibition. Acoustic startle response of animals receiving a single
dose (A,B) or multiple doses of VPA (C,D). (A) Juvenile rats receiving a single
dose of VPA show decreased responses to high intensity acoustic stimuli. (B)
These changes are reversed in adult rats. Juvenile (C) and adult (D) rats
treated with multiple doses of VPA show no difference from controls. (E,F).
Juvenile and adult prepulse inhibition. (E) Juvenile rats treated with a single
dose of VPA show decreased prepulse inhibition. (F)This is reversed in adult
rats. Juvenile and adult rats treated with multiple doses of VPA respond
similarly to controls.
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VPA (n = 13; Figures 2B,D) when compared to their respective
controls.
PREPULSE INHIBITION
Sensorimotor gating is also commonly abnormal in subjects with
sensory processing disturbances, including animals and humans
exposed toVPA in utero (Ardinger et al., 1988;Rogers andOzonoff,
2005; Schneider and Przewlocki, 2005). We assessed sensorimotor
gating with a PPI paradigm. This paradigm quantiﬁes the sup-
pressive effects of a non-startling, antecedent auditory stimulus
on motor responses to a startling stimulus. Juvenile rats treated
in utero with a single dose of VPA (n = 29) exhibited signiﬁcantly
decreased PPI compared to control rats (n = 18; p = 0.03, Mann–
Whitney U ; Figure 2E) whereas juvenile rats treated withmultiple
doses of VPA did not. In adult rats treated with either a single
dose (n = 8) of VPA or multiple doses of VPA (n = 13), PPI was
not signiﬁcantly different (p = 1.00 or 0.11, respectively, Mann–
Whitney U ) than that of their age-matched respective control
groups (Figure 2F).
MECHANICAL AND THERMAL NOCICEPTION
Tactile perception and the perception of pain are commonly
affected in disorders involving disturbed sensory processing (Bar-
Shalita et al., 2009).We assessed mechanical nociceptive responses
with calibrated von Frey ﬁlaments applied either to the face or
hindpaw.
When stimuli were applied to the face, juvenile rats treated
with a single dose of VPA (n = 56 vibrissae pads) showed a
signiﬁcant decrease in threshold (p = 0.005, Mann–Whitney U,
Figure 3A) when compared to controls (n = 26). Juvenile rats
treated with multiple doses of VPA (n = 68) also showed low-
ered thresholds to mechanical stimuli in comparison to control
rats (n = 40, p = 0.04,Mann–Whitney U, Figure 3C).When stim-
uli were applied to the hindpaw, only juvenile rats treated with
a single dose of VPA (n = 56) exhibited a signiﬁcant decrease in
threshold (p = 0.0002,Mann–Whitney U, Figure 3E), whereas the
multiple dose paradigm of VPA (n = 42) had no signiﬁcant effect
(Figure 3G).
In response to stimuli applied to the face, adult rats treated with
a single dose of VPA (n = 16) or multiple doses of VPA (n = 26)
showed similar response probability to their respective control
groups (Figures 3B,D). Similarly, for stimuli applied to the hind-
paw,neither group of adult rats differed signiﬁcantly from controls
(Figures 3F,H).
Another type of perception that is affected in disorders with
disrupted sensory processing disorders is that of thermal pain
(Bar-Shalita et al., 2009).We determined thermal response thresh-
olds using the Hargreaves method (Hargreaves et al., 1988) in
which a heat stimulus is applied to the plantar surface of the rat’s
hindpaw until the paw is withdrawn. Paw withdrawal latencies in
adult rats treated with either a single (n = 16) or multiple doses of
VPA (n = 26) were signiﬁcantly higher (p = 0.003, and p = 0.0003,
respectively,Mann–WhitneyU ) compared to controls (Figure 3I).
No data were collected for thermal latency of juvenile VPA-treated
or age-matched control rats.
SOCIABILITY
Subjects with disorders involving disturbed sensory process-
ing often exhibit abnormal social interaction (Ayres, 1979). We
assessed sociability using an established paradigm (Crawley, 2004)
in which wemonitored the behavior of a freely moving test rat in a
multiple-compartment chamber in which an age and sex-matched
“stranger”rat is restricted to one enclosed compartment (seeMate-
rials and Methods). Juvenile rats treated with a single dose of VPA
(n = 29), but not those treated with multiple doses, spent signif-
icantly less time (p = 0.03, Mann–Whitney U ) with a novel rat
when compared to controls (Figure 4A). Adult rats treated with
either a single dose (n = 8) or multiple doses (n = 13) of VPA also
did not differ from controls (Figure 4B) in the amount of time
they spent with a novel rat.
EXPLORATORY BEHAVIOR
Precedingopenﬁeld testing in juveniles revealed signiﬁcantlymore
exploratory behavior from juveniles treated with a single dose
of VPA (n = 27, p = 0.003, Mann–Whitney U ; Figure 4C). How-
ever, there were no exploratory differences between juvenile rats
treated with multiple doses of VPA or either group of adult rats
(Figure 4D) and their respective control groups.
COLLICULAR ANATOMY
The effects of VPA administration on a number of behav-
iors related to sensory processing suggest that prenatal VPA
administration results in abnormal development of related brain
structures, including the superior colliculus.
We tested this hypothesis by analyzing the superior colli-
culi of adult rats, with the use of stereological procedures (see
Materials and Methods). First, we compared the total num-
ber of Nissl-stained cells in colliculi of animals treated with
single dose of VPA (600mg/kg on E12.5; n = 10) with age-
matched controls (n = 10). There were no signiﬁcant differences
in the total number of cells in the superﬁcial layers (p = 0.26,
Mann–Whitney U ). Control animals had 385,100± 34,000 cells
whereas VPA-treated animals had 314,700± 32,000 cells. Like-
wise, the intermediate/deep showed no difference in Nissl cell
number (p = 0.45, Mann–Whitney U ; control: 745,600± 60,000;
VPA: 644,300± 64,400) layers (Figures 5D,E). There was also
no signiﬁcant difference in volume between treatment and con-
trol groups (p = 0.71, Mann–Whitney U, for superﬁcial and
intermediate/deep layers, respectively). Analysis of the num-
ber of neurons, determined from sections labeled with the
neuron-speciﬁc marker NeuN, also revealed no effects of
VPA treatment on the number of neurons in the superﬁ-
cial (p = 1.0, Mann–Whitney U ) or intermediate/deep (p = 1.0,
Mann–Whitney U ) layers of the superior colliculus. Control
animals (n = 4) had 246,300± 37,900 neurons whereas VPA-
treated animals (n = 4) had 260,000± 5000 neurons in the
superﬁcial layer. In the intermediate/deep layers, control ani-
mals had 353,000± 51000 neurons and VPA-treated animals
had 366,600± 15,700 neurons. Volumetric analysis also revealed
no signiﬁcant differences between VPA-treated and control rats
(p = 1.00, Mann–Whitney U, for both superﬁcial and intermedi-
ate/deep layers).
We reasoned that some of the behavioral effects of VPA might
reﬂect abnormal development of inhibitory neurons in the supe-
rior colliculus. We focused our analysis on inhibitory neurons
that express parvalbumin because these neurons comprise a large
and potent population of GABAergic neurons in various brain
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FIGURE 3 | Effect ofVPA treatment on nociceptive behavior.
(A–D). Stimulus response curves to mechanical stimulation of the
vibrissae pad. Juvenile rats treated with a single dose of VPA
(A) show increased sensitivity to mechanical stimuli. (B)This effect was
reversed in adults. Juvenile (C) and adult (D) rats treated with multiple doses
of VPA show increased sensitivity to mechanical stimuli applied to the face.
(E–F) Stimulus response curves to mechanical stimulation of the hindpaw.
(E) Juvenile rats treated with a single dose of VPA show increased sensitivity
to mechanical stimuli. (F)This is reversed in adults. (G,H) Juvenile and adult
rats treated with multiple doses of VPA respond similarly to controls. (I)
VPA-treated rats show decreased sensitivity to thermal noxious
stimulus.
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FIGURE 4 | Effect ofVPA treatment on sociability and
exploratory behavior. (A) Juvenile rats treated with a single dose of
VPA spend less time with a novel rat. (B)This effect is reversed in
adults. Juvenile and adult rats treated with multiple doses of VPA
respond similarly to controls. (C) Juvenile rats treated with a single
dose of VPA explore more than controls. (D)This is reversed in adults.
Juvenile and adult rats treated with multiple doses of VPA respond similarly
to controls.
regions, including the colliculus (Monyer and Markram, 2004).
We conﬁrmed that parvalbumin is a reliable marker of GABAer-
gic neurons in the colliculus by double labeling for parvalbumin
and GABA (seeMaterials andMethods; Figures 5A–C). Quantita-
tive analysis (six animals, 64 sections, 915 cells) revealed that 95%
of the neurons labeled for parvalbumin were also stained with
the GABA antibody. This ﬁnding indicates that parvalbumin is a
reliablemarker of inhibitory neurons in the rat superior colliculus.
Stereological analysis of sections stained for parvalbumin
revealed that, compared to controls (n = 10), there are about 30%
fewer parvalbumin-positive neurons in VPA-treated rats (n = 10),
both in the superﬁcial (p = 0.04,Mann–WhitneyU ) and interme-
diate/deep layers (p = 0.003, Mann–Whitney U ; Figures 5F,G).
In the superﬁcial layer, adult rats treated with a single dose of
VPA had an average of 19,000± 5,000 parvalbumin-positive neu-
rons whereas control rats had 26,000± 11,000. In the intermedi-
ate/deep layers, the average number of parvalbumin-positive cells
was 14,000± 4,000 in rats that were treated with a single dose of
VPAand21,000± 5000 in controls. Therewasno signiﬁcant differ-
ence in volume between control and treatment groups (p = 0.60
and p = 0.92, Mann–Whitney U for superﬁcial and intermedi-
ate/deep layers, respectively). No data were collected from adult
rats treated with multiple doses of VPA or from any juvenile
rats.
DISCUSSION
Previous studies demonstrated that prenatal exposure to VPA
is teratogenic, resulting not only in gross physical deformations
but also producing behavioral abnormalities (Arpino et al., 2000;
Moore et al., 2000;Alsdorf andWyszynski, 2005;Arndt et al., 2005;
Wyszynski et al., 2005). The current study provides evidence that
VPA also has detrimental effects on sensory processing. This is
manifested as behavioral deﬁcits in sensorimotor tasks, as well as
anatomical abnormalities of the superior colliculus, a structure
known to be involved in sensory processing. These deﬁcits were
typically present in animals that received a single dose of VPA on
E12.5, and most reversed with age.
In most instances, a single dose of VPA at E12.5 (400 or
500mg/kg) resulted in more severe behavioral deﬁcits than mul-
tiple doses of VPA delivered on E11–13 (200mg/kg). This may
indicate that a minimum dose, precise timing of exposure, or the
concurrence of these factors are necessary to precipitate the effects
shown in this study.As the pharmacokinetics of VPA suggest that it
is a quicklymetabolized drug (half life∼2.3 h; Binkerd et al., 1988),
it is highly unlikely that plasma concentrations of VPA would be
additive over consecutive days. Therefore, it would appear that
prenatal exposure to a dose exceeding 200mg/kg on at least E12.5
of gestation is minimally required to elicit behaviors indicative of
dysfunctional sensory processing.
BEHAVIORAL FINDINGS
Startle response and prepulse inhibition
We report that juveniles treated with a single dose of VPA startle
signiﬁcantly less to an unexpected acoustic stimulus across a range
of decibel levels. Our ﬁndings are consistent with previous stud-
ies demonstrating that in utero intra-peritoneal VPA treatment
(500–600mg/kg) has no effect on startle responses of adult rats
(Schneider and Przewlocki, 2005; Markram et al., 2007). By con-
trast, long-term treatment of dams withVPA by gavage is reported
to suppress the startle response of adult rats (Vorhees, 1987). To
our knowledge, ours is the ﬁrst study to test the startle response in
VPA-treated juvenile rats.
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FIGURE 5 | Immunofluorescence double staining for parvalbumin
[green, (A)], GABA [red, (B)], and their colocalization [yellow, (C)].
95% of neurons expressing parvalbumin also express GABA. Arrow in
(C) denotes a GABAergic neuron that is not parvalbumin-positive. Scale
bar=50μm. (D–G). Effects of prenatal VPA treatment on cell numbers
in the superior colliculus of adult rats. (D,E). Total number of
Nissl-stained cells and total number of neurons labeled with NeuN
in the superﬁcial (D) and the intermediate/deep (E) layers. (F,G). VPA
treatment results in signiﬁcant reductions in the number of
parvalbumin-positive neurons in the superﬁcial (F) and the intermediate/deep
(G) layers. Mann–Whitney U used for statistical analyses. Sample size is
denoted by number on each bar.
Our data show that juveniles treated with a single dose of
VPA show a decrease in PPI. We did not observe any signiﬁ-
cant differences in PPI of adult rats. Previous studies reported
that treatment with higher doses of VPA (≥500mg/kg) result in
reductions in PPI in adult rats (Schneider and Przewlocki, 2005;
Markram et al., 2007). It is possible that these results differ from
ours because of differences in the PPI protocol (we used louder
pre-pulses and longer inter-trial intervals) or to differences inVPA
concentrations. We are not aware of similar studies in juvenile,
VPA-treated rats.
Mechanical and thermal nociception
We found that juveniles treated with a single dose of VPA show
hyperalgesia to mechanical stimuli applied to the face or the
hindpaw. Consistent with our ﬁndings, Schneider and Przewlocki
(2005) report that single dose VPA effects on mechanical response
probability are age-dependent, such that young adults (PND
30–50) treated prenatally withVPA have decreased thresholds, but
older adults (PND 90–120) do not. These studies were conducted
only on the hindpaw of the rat. To our knowledge, similar studies
have not been carried out in juvenile rats treated with VPA or on
any rats assessing mechanical response probability of the face.
Our data also show that adult rats treated with either a single
dose or multiple doses of VPA have take longer to withdraw their
paws from a radiant heat source. These results agree with previ-
ous studies showing that adult VPA-treated rats exhibit increased
latency to withdrawing from a thermal stimulus (Schneider et al.,
2001; Schneider and Przewlocki, 2005; Markram et al., 2007).
These data suggest that VPA-treated rats may be less sensitive to
thermal stimuli thanmechanical stimuli, possibly due toVPA’s dis-
tinct mechanism of action on different somatosensory receptors.
Sociability and exploratory behavior
We report that juvenile rats treated with a single dose of VPA
explore more than controls in an open ﬁeld but spend less time
in a social chamber with a stranger rat. This strongly suggests that
our results reﬂect an aversion to exploring a social environment
and not a new environment in general. We did not ﬁnd any dif-
ferences in exploratory behavior or sociability in adults treated
with VPA. Previous studies in which sociability was evaluated by
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monitoring pinning behavior and anogenital inspection report
that adult rats treated with VPA are socially impaired (Schneider
and Przewlocki, 2005; Markram et al., 2007). We are not aware of
other studies using VPA in which adult sociability was measured
using the approach we used, nor are we aware of studies on the
effects of VPA on sociability in juvenile rats.
ANATOMICAL FINDINGS
Our data show that adults treated with a single dose of VPA are not
statistically different from controls in terms of total cell and total
neuronal number in the superior colliculus. However,VPA-treated
rats show signiﬁcant reductions in the number of parvalbumin-
positive neurons. Such a decrease in interneuron number leads to
a change in the synaptic ratio between excitation and inhibition in
this structure.
Disruption in excitation/inhibition balance has long been
linked to behavioral abnormalities and is implicated in numer-
ous psychiatric disorders such as schizophrenia, anxiety, attention
disorders, and autism (Truitt et al., 2007; Gruber et al., 2010;Won
et al., 2011). It is therefore likely that a perturbation of this balance
within the colliculus, such as a change in inhibitory interneu-
rons, may result in abnormal behaviors in colliculus-dependent
behaviors.
While all immunohistochemical ﬁndings are subject to how
well an antigen can be detected by a particular antibody, it is also
important to note that these stereological results yield from VPA-
treated animals that received 600mg/kg of VPA on E12.5. Our
behavioral studies, however, used rats treated with lower doses. It
is possible that the reduction in inhibitory interneurons seen in
this anatomical study would be less dramatic at lower doses of
VPA exposure.
Furthermore, it is unknown if these changes in parvalbumin
are due to VPA directly acting on neurogenesis in the superior
colliculus or whether this teratogen acts to effect the expres-
sion of parvalbumin alone. To date, no studies probing VPA’s
developmental affects, if any,on the colliculus havebeenpublished.
MECHANISMS OF VPA TERATOGENICITY
VPA can act through several biochemical mechanisms. It is
unknown which of these is responsible for the teratogenic conse-
quences,orwhether these are due to a yet to bedeﬁnedmechanism.
The twomost extensively studiedmechanismsbywhichVPAexerts
its actions are as a histone deacetylase I (HDAC) inhibitor and as a
GABA transaminase inhibitor. As anHDAC I inhibitor,VPA exerts
epigenetic regulation on cellular development, affecting temporal
and spatial control of gene activity. Exposure to such an insult dur-
ing prenatal development, a peak time for cell proliferation and
differentiation, is likely to have dire consequences.
VPA is used as an antiseizure agent due to its role as a GABA
transaminase inhibitor: it suppresses the catabolism of GABA
and therefore leads to an increase in GABA levels. This imme-
diate effect may be detrimental to the embryo in at least two
ways. First, because GABA acts as an excitatory neurotransmit-
ter in the embryo (Ben-Ari, 2002; Owens and Kriegstein, 2002),
an increase in GABA concentrations might be excitotoxic (Lom-
bardo et al., 2005; Manent et al., 2007; Levav-Rabkin et al., 2010).
Second, because GABA plays a critical role in guiding embryonic
neuronal migration and development (Loscher, 1982; Leret et al.,
2007), a disruption in GABA concentration gradients is likely to
interfere with the development of the CNS. Both of these mecha-
nisms might contribute to the anatomical and behavioral deﬁcits
reported here.
A transient surge in GABA during embryogenesis can result in
chronic down-regulation of GAD (glutamic acid decarboxylase),
the rate-limiting enzyme in the synthesis of GABA. This chronic
effect – likely affected through VPA’s role as a histone deacetylase
inhibitor (Phiel et al., 2001) – can result in a reduction in GABA
that persists into adulthood (Leret et al., 2007).
Thus, VPA’s effects on the structure of the superior colliculus –
and other affected structures – likely involve both immediate and
lasting effects on GABAmetabolism. In fact, the acute and chronic
effects of VPA on GABA levels, and the ubiquitous distribution of
GABA and its receptors in the nervous system, suggest that embry-
onic exposure toVPAwill likely affect anumberof brain structures.
Indeed, a single injection of VPA at E12.5 – a paradigm used in
the present study – has been previously shown to result in abnor-
malities in a number of CNS regions including the brainstem, the
cerebellum, the neocortex, and the amygdala (Rodier et al., 1996;
Ingram et al., 2000; Markram et al., 2008; Rinaldi et al., 2008a).
Here we demonstrate that VPA alters the anatomy of the superior
colliculus, as well as colliculus-dependent behaviors.
RELEVANCE TO HUMAN DISEASE
Many disorders are associated with abnormal sensory process-
ing. For example, patients with fetal valproate syndrome, autism
spectrum disorders, attention deﬁcit/hyperactivity disorders and
putative sensory processing disorders suffer from sensory pro-
cessing deﬁcits (Mangeot et al., 2001; Baranek et al., 2006, 2007).
Indeed some researchers consider prenatal VPA exposure as a
relevant model for autism (Rodier et al., 1996; Schneider and
Przewlocki, 2005; Wagner et al., 2006; Markram et al., 2007). We
propose thatVPAdisrupts circuitry involved in sensory processing,
a pervasive detriment whose effects encompassmultiple disorders.
In fact, it has been suggested that the behavioral manifestations
of the disorders mentioned above may be due to an underlying
inability to properly process sensory information.A. JeanAyres, an
occupational therapist and developmental psychologist, founded
sensory integration theory, which seeks to make a connection
between deﬁcits in sensory processing and behavioral problems in
school-aged children. She introduced sensory integration therapy
as a treatment for such disturbances in sensory processing (Ayres,
1979). Markram et al. (2007), based on their ﬁndings on VPA’s
effects on CNS development, introduced the concept of “Intense
World Syndrome” in which hyper-reactivity and hyper-plasticity
in the brain’s microcircuits is causally responsible for the sensory
deﬁcits underlying conditions such as autism. Our behavioral and
anatomical ﬁndings are consistentwith these hypotheses, and indi-
cate that the superior colliculus, a structure that plays a key role in
sensorimotor integration, might be involved in the pathogenesis
of these disorders of sensory dysfunction.
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